These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8556947)
1. DNA analysis of in situ ductal carcinoma of the breast via flow cytometry. Ottesen GL; Christensen IJ; Larsen JK; Christiansen J; Hansen B; Andersen JA Cytometry; 1995 Sep; 22(3):168-76. PubMed ID: 8556947 [TBL] [Abstract][Full Text] [Related]
2. Flow cytometric DNA analysis of breast cancers with predominance of carcinoma in situ: a comparison of the premalignant and malignant components. Ottesen GL; Christensen IJ; Larsen JK; Hansen B; Andersen AJ Clin Cancer Res; 1995 Aug; 1(8):881-8. PubMed ID: 9816058 [TBL] [Abstract][Full Text] [Related]
3. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968 [TBL] [Abstract][Full Text] [Related]
4. DNA ploidy analysis in breast carcinoma. Comparison of unfixed and fixed tissue analyzed by image and flow cytometry. Ottesen GL; Christensen IJ; Larsen JK; Larsen J; Christiansen J; Baldetorp B; Linden T; Hansen B; Andersen JA Anal Quant Cytol Histol; 1997 Oct; 19(5):413-22. PubMed ID: 9349901 [TBL] [Abstract][Full Text] [Related]
5. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry. Borgiani L; Cogorno P; Oliviero J; Toso F; Gambini G; Tunesi G; Canepa M Eur J Histochem; 1994; 38(2):171-6. PubMed ID: 7524814 [TBL] [Abstract][Full Text] [Related]
6. DNA ploidy and S-phase fraction by image and flow cytometry in breast cancer fine-needle cytopunctures. Spyratos F; Briffod M Mod Pathol; 1997 Jun; 10(6):556-63. PubMed ID: 9195572 [TBL] [Abstract][Full Text] [Related]
7. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma. Chen TL; Luo I; Mikhail N; Rasková J; Raska K Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949 [TBL] [Abstract][Full Text] [Related]
8. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases. Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306 [TBL] [Abstract][Full Text] [Related]
9. Benign, preinvasive and invasive ductal breast lesions. A comparative study with quantitative techniques: morphometry, image- and flow cytometry. Ruiz A; Almenar S; Callaghan RC; Llombart-Bosch A Pathol Res Pract; 1999; 195(11):741-6. PubMed ID: 10605693 [TBL] [Abstract][Full Text] [Related]
10. [Aneuploidy and proliferative activity in breast cancer (flow-cytometric investigation)]. Bychkova NV; Pozharisskiĭ KM Vopr Onkol; 1997; 43(2):171-5. PubMed ID: 9214117 [TBL] [Abstract][Full Text] [Related]
11. Flow cytometric DNA-analysis of cells obtained with fine needle aspiration biopsy of the breast. Niezabitowski A; Lackowska B; Gruchala A; Ryś J; Jaszcz A; Szklarski W; Wasilewska A; Herman K Gen Diagn Pathol; 1996 Jun; 142(1):33-9. PubMed ID: 8793484 [TBL] [Abstract][Full Text] [Related]
12. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525 [TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of DNA ploidy and S-phase fraction in breast cancer using cells obtained by ex vivo fine-needle aspiration: an optimal method for sample collection. Eliasen CA; Opitz LM; Vamvakas EC; Espiritu EC; Marsh ER; Roses DF; Harris MN; Feiner HD Mod Pathol; 1991 Mar; 4(2):196-200. PubMed ID: 2047382 [TBL] [Abstract][Full Text] [Related]
14. Intratumoral heterogeneity of DNA ploidy in breast carcinomas: a flow cytometric assessment of sampling techniques. Schvimer M; Lash RH; Katzin WE Cytometry; 1995 Dec; 22(4):292-6. PubMed ID: 8749779 [TBL] [Abstract][Full Text] [Related]
15. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast. Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866 [TBL] [Abstract][Full Text] [Related]
16. RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression. Subramaniam MM; Chan JY; Soong R; Ito K; Ito Y; Yeoh KG; Salto-Tellez M; Putti TC Breast Cancer Res Treat; 2009 Jan; 113(1):113-21. PubMed ID: 18256927 [TBL] [Abstract][Full Text] [Related]
17. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor. Xu S; Wei B; Zhang H; Qing M; Bu H Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952 [TBL] [Abstract][Full Text] [Related]
18. [Nuclear DNA content in breast carcinoma by fine needle aspiration biopsy]. Kurihara T; Yokoe T; Iino Y; Ishida T; Morishita Y Nihon Geka Gakkai Zasshi; 1993 Mar; 94(3):277-84. PubMed ID: 8391106 [TBL] [Abstract][Full Text] [Related]
19. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias. Done SJ; Arneson NC; Ozçelik H; Redston M; Andrulis IL Cancer Res; 1998 Feb; 58(4):785-9. PubMed ID: 9485035 [TBL] [Abstract][Full Text] [Related]
20. Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution. Buerger H; Mommers EC; Littmann R; Simon R; Diallo R; Poremba C; Dockhorn-Dworniczak B; van Diest PJ; Boecker W J Pathol; 2001 Jun; 194(2):165-70. PubMed ID: 11400144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]